Lineage Cell Therapeutics, Inc. Payments for Advance to Affiliate
Lineage Cell Therapeutics, Inc. (LCTX) reported Payments for Advance to Affiliate of $50.00 million for the 1-month period ending 2022-01-31, per its 10-Q filed 2022-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForAdvanceToAffiliate · last filed 2023-08-10
- 2022-01-31: Payments for Advance to Affiliate 1 month $50.00M.
- 2021-12-31: Payments for Advance to Affiliate 1 month $50.00M.
- 2021-12-17: Payments for Advance to Affiliate 0 month $50.00M; Payments for Advance to Affiliate $50.00M.
- 2017-06-15: Payments for Advance to Affiliate $50.00M.
| Period end | Payments for Advance to Affiliate 0 month | Payments for Advance to Affiliate | Payments for Advance to Affiliate 1 month |
|---|---|---|---|
| 2022-01-31 | $50.00M 10-Q · filed 2022-11-10 | ||
| 2021-12-31 | $50.00M 10-Q · filed 2022-05-12 | ||
| 2021-12-17 | $50.00M 10-K · filed 2022-03-10 | $50.00M 10-Q · filed 2023-08-10 | |
| 2017-06-15 | $50.00M 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |